Focus: Paradigm Therapeutics is a South Carolina-based biotech company focused on topical therapies across oncology and infectious diseases. The company operates at a modest scale with limited public visibility on employee count or funding.
Profile data last refreshed 10h ago · AI intelligence enriched 1w ago
Suitable only for risk-tolerant early-stage biotech professionals seeking hands-on rare disease experience; limited stability signals warrant due diligence on funding and burn before committing.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Paradigm Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Paradigm Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub